SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-058427
Filing Date
2023-12-19
Accepted
2023-12-19 16:30:29
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 9742
  Complete submission text file 0001140361-23-058427.txt   11768
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GISEV FAMILY OFFICE SA CONTRADA DI SASSELLO 2 LUGANO V8 6900
Business Address
Giuliani Mario Germano (Reporting) CIK: 0001814882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 231497767

Mailing Address C/O GISEV FAMILY OFFICE SA CONTRADA DI SASSELLO 2 LUGANO V8 6900
Business Address C/O GISEV FAMILY OFFICE SA CONTRADA DI SASSELLO 2 LUGANO V8 6900 41919732890
Avara Management Ltd (Reporting) CIK: 0001814934 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 231497768